<DOC>
	<DOCNO>NCT01125475</DOCNO>
	<brief_summary>The primary objective determine adherence RebifÂ® New Formulation administer RebiSmart 12 week therapy patient RRMS .</brief_summary>
	<brief_title>A Scandinavian Non-interventional Study Adherence RebiSmart Administered Rebif New Formulation ( RNF ) Treatment Relapsing Remitting Multiple Sclerosis ( RRMS ) Subjects</brief_title>
	<detailed_description />
	<mesh_term>Sclerosis</mesh_term>
	<mesh_term>Multiple Sclerosis</mesh_term>
	<mesh_term>Multiple Sclerosis , Relapsing-Remitting</mesh_term>
	<mesh_term>Interferon beta-1a</mesh_term>
	<criteria>Males females 18 65 year age Have relapsingremitting multiple sclerosis ( RRMS ) accord revise McDonald Criteria ( 2005 ) Having expand disability status scale ( EDSS ) less 6 screen visit within 2 month prior screen visit Stable treatment ( define treatment titration period ) RebiSmart administer Rebif new formulation ( RNF ) 22/44 mcg subcutaneously thrice week minimum 4 week prior inclusion Previously treat disease modify drug ( DMDs ) minimum 6 month prior screen visit Female subject must neither pregnant breastfeeding must lack childbearing potential define either : Postmenopausal surgically sterile ; Using highly effective method contraception duration study . This define method result low failure rate ( i.e . le 1 % per year ) use consistently correctly , include instance implant , injectables , combine oral contraceptive , intrauterine device ( IUD ) , sexual abstinence vasectomize partner Have schedule visit 12 week inclusion visit Willing able comply protocol duration study Have give write informed consent Have relapse within 30 day prior first visit Have contraindication treatment Interferonbeta 1a accord Summary Product Characteristics Have significant disease Investigator 's opinion would exclude subject trial</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>September 2012</verification_date>
	<keyword>Relapsing Remitting Multiple Sclerosis</keyword>
	<keyword>RebiSmart</keyword>
	<keyword>Rebif</keyword>
	<keyword>Adherence</keyword>
</DOC>